Feedback / Questions
AiTan (rivoceranib) - Elevar Therapeutics
AiRuiKa (camrelizumab) - Elevar Therapeutics
https://www.cancernetwork.com/view/camrelizumab-plus-rivoceranib-tace-improve-pfs-increases-toxicity-in-uhcc
Jun 2, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next